dapsone has been researched along with Adamantiades-Behcet Disease in 19 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "In dapsone-treated patients, there were significant reductions in the oral and genital ulcer parameters as well as the incidence of other cutanous and systemic manifestations." | 2.70 | Dapsone in Behçet's disease: a double-blind, placebo-controlled, cross-over study. ( Abu-Raghif, AR; Najim, RA; Sharquie, KE, 2002) |
| "Patients with Behcet's disease without oral ulcers and other diagnoses such as pemphigus vulgaris, lichen planus and herpes simplex were excluded." | 1.38 | Oral aphthosis: management gaps and recent advances. ( Liang, MW; Neoh, CY, 2012) |
| "Neutrophilic eccrine hidradenitis (NEH) is a rare distinct entity that usually presents as asymptomatic erythematous papules that disappear spontaneously in 1-3 weeks." | 1.31 | Chronic pruritic neutrophilic eccrine hidradenitis in a patient with Behçet's disease. ( Lambert, J; Meuleman, L; Nijsten, TE, 2002) |
| "All patients had oral and genital aphthae, and 22 of 25 patients had cutaneous lesions consistent with Behçet's disease." | 1.29 | Behçet's disease. Report of twenty-five patients from the United States with prominent mucocutaneous involvement. ( Jorizzo, JL; Mangelsdorf, HC; White, WL, 1996) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (21.05) | 18.7374 |
| 1990's | 1 (5.26) | 18.2507 |
| 2000's | 10 (52.63) | 29.6817 |
| 2010's | 4 (21.05) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Rotondo, C | 1 |
| Lopalco, G | 1 |
| Iannone, F | 1 |
| Vitale, A | 1 |
| Talarico, R | 1 |
| Galeazzi, M | 1 |
| Lapadula, G | 1 |
| Cantarini, L | 1 |
| Fatima, J | 1 |
| Shukla, V | 1 |
| Karoli, R | 1 |
| Altiner, A | 1 |
| Mandal, R | 1 |
| Liang, MW | 1 |
| Neoh, CY | 1 |
| Nijsten, TE | 1 |
| Meuleman, L | 1 |
| Lambert, J | 1 |
| Vidaller Palacín, A | 1 |
| Robert Olalla, J | 1 |
| Sanuy Jiménez, B | 1 |
| Rufi Rigau, G | 1 |
| Folch Civit, J | 1 |
| Charte González, A | 1 |
| Najim, RA | 3 |
| Sharquie, KE | 4 |
| Al-Janabi, MH | 2 |
| Yurdakul, S | 1 |
| Hamuryudan, V | 1 |
| Yazici, H | 1 |
| Joshi, A | 1 |
| Chawla, S | 1 |
| Smart, CJ | 1 |
| Moots, RJ | 1 |
| Convit, J | 1 |
| Goihman-Yahr, M | 1 |
| Rondón-Lugo, AJ | 1 |
| Mangelsdorf, HC | 1 |
| White, WL | 1 |
| Jorizzo, JL | 1 |
| Kaklamani, VG | 1 |
| Kaklamanis, PG | 1 |
| Aynacioglu, AS | 1 |
| Bozkurt, A | 1 |
| Nacak, M | 1 |
| Kortunay, S | 1 |
| Tunc, R | 1 |
| Dincel, A | 1 |
| Kayaalp, SO | 1 |
| Abu-Raghif, AR | 1 |
| Hamza, M | 1 |
| Hamzaoui, K | 1 |
| Ayed, K | 1 |
| Kursanov, IuV | 1 |
| Sheĭnkman, EV | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Randomized, Double Blinded, Placebo-controlled Trial to Assess the Preventive Effects of Cetylpyridinium Chloride on Sarcopenia[NCT02575235] | Early Phase 1 | 100 participants (Actual) | Interventional | 2015-10-01 | Completed | ||
| Randomized, Double Blinded, Placebo-controlled Trial to Assess the Preventive Effects of Cetylpyridinium Chloride on Sarcopenia: An Exploratory Pilot Study[NCT02297997] | Early Phase 1 | 65 participants (Actual) | Interventional | 2014-11-13 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
3 reviews available for dapsone and Adamantiades-Behcet Disease
| Article | Year |
|---|---|
Mucocutaneous Involvement in Behçet's Disease: How Systemic Treatment Has Changed in the Last Decades and Future Perspectives.
Topics: Anti-Bacterial Agents; Azathioprine; Behcet Syndrome; Colchicine; Dapsone; Humans; Interferon-alpha; | 2015 |
[Behcet's disease therapy review].
Topics: Behcet Syndrome; Colchicine; Dapsone; Humans; Methotrexate; Prednisone; Thalidomide | 2002 |
Behçet syndrome.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antiviral Agents; Autoantibodies; Behcet Syndrome; Dapsone; | 2004 |
1 trial available for dapsone and Adamantiades-Behcet Disease
| Article | Year |
|---|---|
Dapsone in Behçet's disease: a double-blind, placebo-controlled, cross-over study.
Topics: Administration, Oral; Adult; Anti-Inflammatory Agents, Non-Steroidal; Behcet Syndrome; Cross-Over St | 2002 |
Dapsone in Behçet's disease: a double-blind, placebo-controlled, cross-over study.
Topics: Administration, Oral; Adult; Anti-Inflammatory Agents, Non-Steroidal; Behcet Syndrome; Cross-Over St | 2002 |
Dapsone in Behçet's disease: a double-blind, placebo-controlled, cross-over study.
Topics: Administration, Oral; Adult; Anti-Inflammatory Agents, Non-Steroidal; Behcet Syndrome; Cross-Over St | 2002 |
Dapsone in Behçet's disease: a double-blind, placebo-controlled, cross-over study.
Topics: Administration, Oral; Adult; Anti-Inflammatory Agents, Non-Steroidal; Behcet Syndrome; Cross-Over St | 2002 |
15 other studies available for dapsone and Adamantiades-Behcet Disease
| Article | Year |
|---|---|
Behcet's syndrome presenting as FUO.
Topics: Adolescent; Behcet Syndrome; Colchicine; Dapsone; Dexamethasone; Diagnosis, Differential; Female; Fe | 2010 |
Behçet syndrome.
Topics: Adult; Behcet Syndrome; Dapsone; Dietary Supplements; Glucocorticoids; Humans; Male; Silver Nitrate; | 2010 |
Oral aphthosis: management gaps and recent advances.
Topics: Adolescent; Adrenal Cortex Hormones; Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Anti-Inf | 2012 |
Chronic pruritic neutrophilic eccrine hidradenitis in a patient with Behçet's disease.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Behcet Syndrome; Chronic Disease; Dapsone; Female; Hidraden | 2002 |
Acetylator phenotype in Behçet's disease.
Topics: Acetylation; Adult; Arylamine N-Acetyltransferase; Behcet Syndrome; Dapsone; Female; Folic Acid Anta | 2003 |
Acetylator phenotype in Behçet's disease.
Topics: Acetylation; Adult; Age of Onset; Behcet Syndrome; Biotransformation; Dapsone; Female; HLA-B Antigen | 2003 |
Behçet's syndrome with pyoderma-gangrenosum-like lesions treated successfully with dapsone monotherapy.
Topics: Administration, Oral; Aged; Anti-Bacterial Agents; Behcet Syndrome; Combined Modality Therapy; Dapso | 2004 |
Recto-vaginal fistula: a refractory complication of Behcet's disease.
Topics: Adult; Antibodies, Monoclonal; Behcet Syndrome; Dapsone; Disease Progression; Female; Humans; Inflam | 2007 |
Effectiveness of dapsone in Behcet's disease.
Topics: Behcet Syndrome; Dapsone; Humans; Recurrence; Stomatitis, Aphthous | 1984 |
Suppression of Behçet's disease with dapsone.
Topics: Adult; Behcet Syndrome; Dapsone; Humans; Male | 1984 |
Behçet's disease. Report of twenty-five patients from the United States with prominent mucocutaneous involvement.
Topics: Administration, Topical; Adolescent; Adult; Aged; Anti-Inflammatory Agents; Behcet Syndrome; Colchic | 1996 |
Treatment of Behçet's disease--an update.
Topics: Adrenal Cortex Hormones; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Behcet Syndrome; Chl | 2001 |
N-acetyltransferase polymorphism in patients with Behçet's disease.
Topics: Acetylation; Adult; Arylamine N-Acetyltransferase; Behcet Syndrome; Dapsone; Female; Gene Frequency; | 2001 |
Treatment of Behçet's disease with dapsone.
Topics: Adult; Behcet Syndrome; Dapsone; Female; Humans; Male; Middle Aged | 1989 |
[Behcet's syndrome].
Topics: Adult; Aloe; Behcet Syndrome; Dapsone; Humans; Male; Phytotherapy; Plants, Medicinal | 1973 |